ZA847890B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA847890B
ZA847890B ZA847890A ZA847890A ZA847890B ZA 847890 B ZA847890 B ZA 847890B ZA 847890 A ZA847890 A ZA 847890A ZA 847890 A ZA847890 A ZA 847890A ZA 847890 B ZA847890 B ZA 847890B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA847890A
Other languages
English (en)
Inventor
Eberhard Fritz Gottwald
Horst Manfred Machoczek
Original Assignee
Smithkline Dauelsberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Dauelsberg filed Critical Smithkline Dauelsberg
Publication of ZA847890B publication Critical patent/ZA847890B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA847890A 1983-10-10 1984-10-09 Pharmaceutical compositions ZA847890B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP83306112 1983-10-10

Publications (1)

Publication Number Publication Date
ZA847890B true ZA847890B (en) 1985-05-29

Family

ID=8191309

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA847890A ZA847890B (en) 1983-10-10 1984-10-09 Pharmaceutical compositions

Country Status (10)

Country Link
US (1) US4861592A (da)
EP (1) EP0138540B1 (da)
JP (1) JPS61500223A (da)
AU (1) AU560608B2 (da)
CA (1) CA1239349A (da)
DE (1) DE3467703D1 (da)
DK (1) DK163959C (da)
IE (1) IE57706B1 (da)
WO (1) WO1985001656A1 (da)
ZA (1) ZA847890B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036479A (ja) * 1983-08-08 1985-02-25 Kotobuki Seiyaku Kk １，３−ジオキサン誘導体、本化合物を有効成分とする抗潰瘍剤及びその製造方法
US5994041A (en) * 1985-04-06 1999-11-30 Eastman Kodak Company Process for buffering concentrated aqueous slurries
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
NL194638C (nl) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
EP0294933B1 (en) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmaceutical compositions
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
JP2643260B2 (ja) * 1988-03-22 1997-08-20 藤沢薬品工業株式会社 シロップ剤
US5226901A (en) * 1988-04-11 1993-07-13 Dhaliwal Avtar S Composite anesthetic article and method of use
US5209724A (en) * 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
EP0663818A4 (en) * 1992-09-03 1996-04-24 Ibah Inc TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME.
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
AU6774694A (en) * 1993-04-26 1994-11-21 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
US5609998A (en) * 1994-12-29 1997-03-11 Eastman Kodak Company Process for dispersing concentrated aqueous slurries
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
JP2001501224A (ja) * 1996-10-04 2001-01-30 メルク エンド カンパニー インコーポレーテッド 胸焼けを予防及び治療するための方法及び組成物
US5989588A (en) * 1996-10-04 1999-11-23 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
AU730391B2 (en) * 1996-10-10 2001-03-08 Mcneil-Ppc, Inc. Liquid antacid compositions
RU2184570C2 (ru) * 1997-09-30 2002-07-10 Дайити Фармасьютикал Ко., Лтд. Препараты для орального введения
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
AR051397A1 (es) * 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
EP1983827A4 (en) 2006-02-01 2013-07-10 Stuart L Weg USE OF ANTIFUNGAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL CONDITIONS
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
BR112013020237A2 (pt) * 2011-02-11 2021-03-16 Ctc Bio, Inc. Processo para preparar um filme contendo base livre de sildenafila e filme contendo base livre de sildenafila
EP2952103B1 (de) * 2014-06-05 2019-05-08 Symrise AG Stoffgemische

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1550359A (en) * 1975-08-07 1979-08-15 Beecham Group Ltd Antibiotic compositions for oral administration
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids

Also Published As

Publication number Publication date
WO1985001656A1 (en) 1985-04-25
DK257485D0 (da) 1985-06-07
JPS61500223A (ja) 1986-02-06
EP0138540B1 (en) 1987-11-25
EP0138540A3 (en) 1985-05-22
DK257485A (da) 1985-06-07
AU560608B2 (en) 1987-04-09
AU3503984A (en) 1985-05-07
US4861592A (en) 1989-08-29
CA1239349A (en) 1988-07-19
DK163959C (da) 1992-09-21
IE57706B1 (en) 1993-03-10
IE842579L (en) 1985-04-10
DK163959B (da) 1992-04-27
EP0138540A2 (en) 1985-04-24
DE3467703D1 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
GB2136807B (en) Pharmaceutical compositions
GB8423339D0 (en) Pharmaceutical compositions
GB8403668D0 (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8313217D0 (en) Pharmaceutical compositions
GB8415975D0 (en) Pharmaceutical compositions
GR80445B (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
GR80444B (en) Pharmaceutical compositions
GB8427485D0 (en) Pharmaceutical compositions
GB2136806B (en) Pharmaceutical compositions
GB8317595D0 (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
GB8412569D0 (en) Pharmaceutical compositions
GB8323553D0 (en) Pharmaceutical compositions
GB8406132D0 (en) Pharmaceutical compositions
EP0136006A3 (en) Pharmaceutical compositions
GB8300767D0 (en) Pharmaceutical compositions
GB8416358D0 (en) Pharmaceutical compositions
GB8305697D0 (en) Pharmaceutical compositions
GB8425250D0 (en) Pharmaceutical compositions
GB2150435B (en) Pharmaceutical compositions
GB8323623D0 (en) Pharmaceutical compositions
GB8304870D0 (en) Pharmaceutical compositions
IE830600L (en) Pharmaceutical compositions